164 related articles for article (PubMed ID: 10566383)
1. Tool support for authoring eligibility criteria for cancer trials.
Rubin DL; Gennari JH; Srinivas S; Yuen A; Kaizer H; Musen MA; Silva JS
Proc AMIA Symp; 1999; ():369-73. PubMed ID: 10566383
[TBL] [Abstract][Full Text] [Related]
2. Cross-tool communication: from protocol authoring to eligibility determination.
Gennari JH; Sklar D; Silva J
Proc AMIA Symp; 2001; ():199-203. PubMed ID: 11825180
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials referral resource. Non-small-cell lung cancer.
Cheson BD
Oncology (Williston Park); 1990 Feb; 4(2):51-63. PubMed ID: 2167113
[No Abstract] [Full Text] [Related]
4. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials.
Horn L; Keedy VL; Campbell N; Garcia G; Hayes A; Spencer B; Carbone DP; Sandler A; Johnson DH
Clin Lung Cancer; 2013 Jan; 14(1):14-8. PubMed ID: 22591607
[TBL] [Abstract][Full Text] [Related]
5. Cancer trial enrollment after state-mandated reimbursement.
Gross CP; Murthy V; Li Y; Kaluzny AD; Krumholz HM
J Natl Cancer Inst; 2004 Jul; 96(14):1063-9. PubMed ID: 15265967
[TBL] [Abstract][Full Text] [Related]
6. Finding appropriate clinical trials: evaluating encoded eligibility criteria with incomplete data.
Ash N; Ogunyemi O; Zeng Q; Ohno-Machado L
Proc AMIA Symp; 2001; ():27-31. PubMed ID: 11825151
[TBL] [Abstract][Full Text] [Related]
7. A method for discovering and inferring appropriate eligibility criteria in clinical trial protocols without labeled data.
Restificar A; Korkontzelos I; Ananiadou S
BMC Med Inform Decis Mak; 2013; 13 Suppl 1(Suppl 1):S6. PubMed ID: 23566239
[TBL] [Abstract][Full Text] [Related]
8. Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment.
Filion M; Forget G; Brochu O; Provencher L; Desbiens C; Doyle C; Poirier B; DuRocher M; Camden S; Lemieux J
Clin Trials; 2012 Oct; 9(5):652-9. PubMed ID: 23060323
[TBL] [Abstract][Full Text] [Related]
9. Knowledge representation and tool support for critiquing clinical trial protocols.
Rubin DL; Gennari J; Musen MA
Proc AMIA Symp; 2000; ():724-8. PubMed ID: 11079979
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials in a rural population: professional education aspects.
Maurer LH; Davis T; Hammond S; Smith E; West P; Doolittle M
J Cancer Educ; 2001; 16(2):89-92. PubMed ID: 11440069
[TBL] [Abstract][Full Text] [Related]
11. Supporting patient screening to identify suitable clinical trials.
Bucur A; Van Leeuwen J; Chen NZ; Claerhout B; De Schepper K; Perez-Rey D; Alonso-Calvo R; Pugliano L; Saini K
Stud Health Technol Inform; 2014; 205():823-7. PubMed ID: 25160302
[TBL] [Abstract][Full Text] [Related]
12. Conformity between protocol eligibility criteria for electronic patient identification: a comparison of clinical trials.
Kamauu A; Agbor S; Kamauu A
Stud Health Technol Inform; 2013; 192():1167. PubMed ID: 23920941
[TBL] [Abstract][Full Text] [Related]
13. Has demand for clinical trial participants outpaced supply?
Tam-McDevitt JT; Balducci L; Hauser RS; Gura D; Paraghamian A; Thomas H; Lichtman SM
J Natl Cancer Inst; 2007 Jan; 99(1):86-7. PubMed ID: 17202120
[No Abstract] [Full Text] [Related]
14. Computer-based screening of patients with HIV/AIDS for clinical-trial eligibility.
Carlson RW; Tu SW; Lane NM; Lai TL; Kemper CA; Musen MA; Shortliffe EH
Online J Curr Clin Trials; 1995 Mar; Doc No 179():[3347 words; 32 paragraphs]. PubMed ID: 7719564
[TBL] [Abstract][Full Text] [Related]
15. Analysis of eligibility criteria representation in industry-standard clinical trial protocols.
Bhattacharya S; Cantor MN
J Biomed Inform; 2013 Oct; 46(5):805-13. PubMed ID: 23770150
[TBL] [Abstract][Full Text] [Related]
16. Decision support for clinical trial eligibility determination in breast cancer.
Ohno-Machado L; Wang SJ; Mar P; Boxwala AA
Proc AMIA Symp; 1999; ():340-4. PubMed ID: 10566377
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Eligibility Criteria Between Protocols, Registries, and Publications of Cancer Clinical Trials.
Zhang S; Liang F; Li W; Tannock I
J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27226519
[TBL] [Abstract][Full Text] [Related]
18. PAT: an intelligent authoring tool for facilitating clinical trial design.
Tagaris A; Andronikou V; Karanastasis E; Chondrogiannis E; Tsirmpas C; Varvarigou T; Koutsouris D
Stud Health Technol Inform; 2014; 205():970-4. PubMed ID: 25160332
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of eligibility and recruitment in breast cancer clinical trials.
Lemieux J; Forget G; Brochu O; Provencher L; Cantin G; Desbiens C; Doyle C; Poirier B; Camden S; Durocher M
Breast; 2014 Aug; 23(4):385-92. PubMed ID: 24679829
[TBL] [Abstract][Full Text] [Related]
20. Enhancing reuse of structured eligibility criteria and supporting their relaxation.
Milian K; Hoekstra R; Bucur A; Ten Teije A; van Harmelen F; Paulissen J
J Biomed Inform; 2015 Aug; 56():205-19. PubMed ID: 26015310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
